Provided by Tiger Trade Technology Pte. Ltd.

Imunon, Inc.

1.64
+0.06003.80%
Post-market: 1.650.0052+0.32%19:59 EDT
Volume:58.85K
Turnover:95.07K
Market Cap:9.20M
PE:-0.46
High:1.67
Open:1.61
Low:1.59
Close:1.58
52wk High:6.96
52wk Low:1.47
Shares:5.61M
Float Shares:5.32M
Volume Ratio:0.68
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5719
EPS(LYR):-6.8265
ROE:-429.72%
ROA:-77.99%
PB:4.75
PE(LYR):-0.24

Loading ...

Imunon Initiated at Buy by Maxim Group

Dow Jones
·
Apr 17

Imunon initiated with a Buy at Maxim

TIPRANKS
·
Apr 17

Analysts Offer Insights on Healthcare Companies: Imunon (IMNN), Axsome Therapeutics (AXSM) and Oric Pharmaceuticals (ORIC)

TIPRANKS
·
Apr 02

Analysts Have Conflicting Sentiments on These Healthcare Companies: Imunon (IMNN) and Novo Nordisk (NVO)

TIPRANKS
·
Apr 01

Imunon FY25 net loss narrows 22% to $14.5 million; cash climbs to $8.8 million

Reuters
·
Apr 01

BRIEF-Imunon Reports 2025 Financial Results And Provides Business Update

Reuters
·
Mar 31

Imunon Q4 EPS $(1.30) Misses $(1.13) Estimate

Benzinga Earnings
·
Mar 31

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 30

Imunon Inc expected to post a loss of $1.17 a share - Earnings Preview

Reuters
·
Mar 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 27

BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings

Reuters
·
Mar 26

Imunon announces final clinical data from OVATION 2 clinical trial

TIPRANKS
·
Mar 25

Imunon: Patients Treated With Parp Inhibitor Therapy With Imnn-001 & Standard of Care Chemotherapy Showed Median Increase in Os of 24.2 Mnths

THOMSON REUTERS
·
Mar 25

Imunon Reports Updated Phase 2 Data Showing Continued Improvement in Median Overall Survival With Imnn-001 in Women With Newly Diagnosed Advanced Ovarian Cancer

THOMSON REUTERS
·
Mar 25

Imunon: Rise in Median Overall Survival Among Women Treated With Imnn-001 in Ovation 2 Trial Rose From 11.1 Mnths to 14.7 Mnths

THOMSON REUTERS
·
Mar 25

Imunon reports Phase 2 OVATION 2 data; median overall survival rises by 14.7 months with IMNN-001 in newly diagnosed advanced ovarian cancer

Reuters
·
Mar 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 25

Imunon to host year-end 2025 financial results conference call

Reuters
·
Mar 24

Imunon files prospectus supplement for USD 7 million at-the-market common stock offering

Reuters
·
Mar 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 23